“Our study demonstrated in a large real-world population that long-term treatment of up to 5 years with adalimumab in adult patients with psoriasis led to a sustained improvement in the practice of ...
Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback